Philadelphia abruptly ends briefly revived indoor mask requirement amid falling COVID-19 hospitalizations

Philadelphia's new public indoor masking requirement, which took effect Monday, is ending Friday morning, city health officials said Thursday night. The city Board of Health said it voted to rescind the mandate Thursday in part because of "decreasing hospitalizations and a leveling of case counts." The health board's April 11 announcement that masks would be required again was also met with threats of legal challenges.
"We're in a situation that we really had not anticipated being in this soon, but it is good news," acting Philadelphia health commissioner Dr. Cheryl Bettigole said at Thursday's meeting. "So I'm really very happy ... to say it appears that we no longer need to mandate masks in Philadelphia and that we can actually move to simply a strong recommendation."
When Philadelphia became the first major U.S. city to re-institute a mask mandate amid rising COVID-19 infections, health officials cited rising infection and hospitalization numbers. And both numbers continued to rise at least through Monday, when 82 people were reported hospitalized with COVID-19, Bettigole said Thursday, but they then unexpectedly dropped 25 percent in the next couple of days.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
How worried should we be about asteroids?
Today's Big Question Odds of asteroid 2024 YR4 hitting Earth have fluctuated wildly this week
By Chas Newkey-Burden, The Week UK Published
-
Why does Elon Musk take his son everywhere?
Talking Point With his four-year-old 'emotional support human' by his side, what message is the world's richest man sending?
By Rebekah Evans, The Week UK Published
-
The Week Unwrapped: Why are sinkholes becoming more common?
Podcast Plus, will Saudi investment help create the "Netflix of sport"? And why has New Zealand's new tourism campaign met with a savage reception?
By The Week UK Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
Oysters could help combat antibiotic resistance
Under the radar The mollusk shows infection-fighting abilities
By Devika Rao, The Week US Published
-
How Trump's executive orders are threatening scientific research
In the spotlight Agencies are purging important health information
By Devika Rao, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
America is leaving WHO. What does that mean for public health?
Today's Big Question Trump orders the withdrawal
By Joel Mathis, The Week US Published